pISSN 1738-6756   eISSN 2092-9900
Open Access, Peer-reviewed
    J Breast Cancer. 2011 Feb;14(Suppl 1):S64-S69. Korean.
    Published online Feb 28, 2011.
    https://doi.org/10.4048/jbc.2011.14.S.S64
    Copyright © 2011 Korean Breast Cancer Society
    Original Article

    Depressive Symptom-Related Factors in Patients with Breast Cancer

    Eun Young Park, Young Tae Bae, Jee Yeon Lee, Hyung-Il Seo, Eun Soo Moon,1 and Youn Joo Jung2
      • Department of Surgery, Postgraduate College of Medicine, Pusan National University, Busan, Korea.
      • 1Department of Psychiatry, Postgraduate College of Medicine, Pusan National University, Busan, Korea.
      • 2Breast Cancer Center, Postgraduate College of Medicine, Pusan National University, Busan, Korea.
    • Correspondence: Email: bytae@pusan.ac.kr
    Received September 02, 2010; Accepted January 12, 2011.

    Abstract

    Purpose

    Patients with breast cancer are at risk for developing psychological distress and psychiatric disorders such as depression. The aim of this study was to assess the depressive symptom related factors in women with breast cancer.

    Methods

    A total of 211 patients with breast cancer who had undergone an operation within 5 years participated in this survey with consent. Depressive symptoms in patients were measured using the 21-item Beck Depression Inventory (BDI) questionnaire in the outpatient clinic and sociodemographic, clinicopathologic factors of the patients were analyzed with a BDI score. The patients were divided into group A (BDI<16, n=146) and group B (BDI≥16, n=65).

    Results

    The mean age of the patients was 49.2 years and the mean follow-up period was 22 months. In the univariate analyses, postmenopausal status (p=0.014), tumor size (p=0.023) and presence of progesterone receptor (p=0.012) were significantly associated with depressive symptom. In multivariate analysis, only postmenopause (p=0.021) and tumor size (p=0.018) were related with depressive symptom.

    Conclusion

    Depressive symptom is common in patients with breast cancer and a screening test for depression is needed in breast cancer patient who experienced menopause or has bigger tumor size.

    Keywords
    Breast neoplasms; Depressive symptom; Postmenopause; Tumor size

    Tables

    Table 1
    Sociodemographic factors associated with depressive symptom in breast cancer patients

    Table 2
    Clinicopathologic factors associated with depressive symptom in breast cancer patients

    Table 3
    Multivariate analysis for factors associated with depressive symptom in patients with breast cancer

    References

      1. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004;32:57–71.
      1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8–19.
      1. Ahn SH, Yoo KY. Korean Breast Cancer Society. Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996-2004. Breast Cancer Res Treat 2006;99:209–214.
      1. Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L. Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res Treat 1996;38:183–199.
      1. Somerset W, Stout SC, Miller AH, Musselman D. Breast cancer and depression. Oncology (Williston Park) 2004;18:1021–1034.
      1. Ayres A, Hoon PW, Franzoni JB, Matheny KB, Cotanch PH, Takayanagi S. Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients. J Psychosom Res 1994;38:393–402.
      1. Watson M, Haviland JS, Greer S, Davidson J, Bliss JM. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999;354:1331–1336.
      1. Hjerl K, Andersen EW, Keiding N, Mouridsen HT, Mortensen PB, Jorgensen T. Depression as a prognostic factor for breast cancer mortality. Psychosomatics 2003;44:24–30.
      1. Kim SH, Son BH, Hwang SY, Han W, Yang JH, Lee S, et al. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manage 2008;35:644–655.
      1. Leedham B, Ganz PA. Psychosocial concerns and quality of life in breast cancer survivors. Cancer Invest 1999;17:342–348.
      1. Lee YH, Song JY. A study of the reliability and the validity of the BDI, SDS, and MMPI-D scales. Korean J Clin Psychol 1991;10:98–113.
      1. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–571.
      1. Shin MS, Kim JS, Park KB. The cut-off score for the Korean version of Beck Depression Inventory. Korean J Clin Psychol 1993;12:71–81.
      1. Riolo SA, Nguyen TA, Greden JF, King CA. Prevalence of depression by race/ethnicity: findings from the National Health and Nutrition Examination Survey III. Am J Public Health 2005;95:998–1000.
      1. Rush AJ. The varied clinical presentations of major depressive disorder. J Clin Psychiatry 2007;68 Suppl 8:4–10.
      1. Bardwell WA, Natarajan L, Dimsdale JE, Rock CL, Mortimer JE, Hollenbach K, et al. Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol 2006;24:2420–2427.
      1. Chen X, Zheng Y, Zheng W, Gu K, Chen Z, Lu W, et al. Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncol 2009;48:1128–1136.
      1. Christensen S, Zachariae R, Jensen AB, Vaeth M, Moller S, Ravnsbaek J, et al. Prevalence and risk of depressive symptoms 3-4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat 2009;113:339–355.
      1. Kim SW, Kim SY, Kim JM, Park MH, Yoon JH, Shin IS, et al. Use of antidepressants in patients with breast cancer. Korean J Psychopharmacol 2009;20:63–77.
      1. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63:375–382.
      1. Ell K, Sanchez K, Vourlekis B, Lee PJ, Dwight-Johnson M, Lagomasino I, et al. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol 2005;23:3052–3060.
      1. Cathcart CK, Jones SE, Pumroy CS, Peters GN, Knox SM, Cheek JH. Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 1993;27:277–281.
      1. Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 2005;330:702.
      1. Aragona M, Muscatello MR, Mesiti M. Depressive mood disorders in patients with operable breast cancer. J Exp Clin Cancer Res 1997;16:111–118.
      1. Lee KC, Ray GT, Hunkeler EM, Finley PR. Tamoxifen treatment and new-onset depression in breast cancer patients. Psychosomatics 2007;48:205–210.
      1. Toney SD. Identifying and managing depression in women. J Manag Care Pharm 2007;13 9 Suppl A:S16–S22.
      1. Hintikka J, Pesonen T, Saarinen P, Tanskanen A, Lehtonen J, Viinamaki H. Suicidal ideation in the Finnish general population. A 12-month follow-up study. Soc Psychiatry Psychiatr Epidemiol 2001;36:590–594.
      1. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003;289:3243–3253.
    MeSH Terms
    Breast Neoplasms
    Female
    Humans
    Metrics
    Share
    Tables
    slide
    slide
    slide

    1 / 3

    PERMALINK